- Home
- TXMD vs GWAV Comparison
TXMD vs GWAV Comparison
Compare TXMD & GWAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXMD
- GWAV
- Stock Information
- Founded
- TXMD 2008
- GWAV 2002
- Country
- TXMD United States
- GWAV United States
- Employees
- TXMD N/A
- GWAV N/A
- Industry
- TXMD Biotechnology: Pharmaceutical Preparations
- GWAV Packaged Foods
- Sector
- TXMD Health Care
- GWAV Consumer Staples
- Exchange
- TXMD Nasdaq
- GWAV Nasdaq
- Market Cap
- TXMD 12.7M
- GWAV 12.8M
- IPO Year
- TXMD N/A
- GWAV N/A
- Fundamental
- Price
- TXMD $1.17
- GWAV $0.18
- Analyst Decision
- TXMD
- GWAV
- Analyst Count
- TXMD 0
- GWAV 0
- Target Price
- TXMD N/A
- GWAV N/A
- AVG Volume (30 Days)
- TXMD 23.3K
- GWAV 1.7M
- Earning Date
- TXMD 08-12-2025
- GWAV 08-22-2025
- Dividend Yield
- TXMD N/A
- GWAV N/A
- EPS Growth
- TXMD N/A
- GWAV N/A
- EPS
- TXMD N/A
- GWAV N/A
- Revenue
- TXMD $1,841,000.00
- GWAV $33,315,859.00
- Revenue This Year
- TXMD $427.09
- GWAV N/A
- Revenue Next Year
- TXMD N/A
- GWAV N/A
- P/E Ratio
- TXMD N/A
- GWAV N/A
- Revenue Growth
- TXMD 53.55
- GWAV N/A
- 52 Week Low
- TXMD $0.70
- GWAV $0.12
- 52 Week High
- TXMD $2.44
- GWAV $1.09
- Technical
- Relative Strength Index (RSI)
- TXMD 54.93
- GWAV 40.27
- Support Level
- TXMD $1.06
- GWAV $0.18
- Resistance Level
- TXMD $1.12
- GWAV $0.19
- Average True Range (ATR)
- TXMD 0.04
- GWAV 0.01
- MACD
- TXMD 0.01
- GWAV -0.00
- Stochastic Oscillator
- TXMD 73.27
- GWAV 11.69
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About GWAV Greenwave Technology Solutions Inc.
Greenwave Technology Solutions Inc through its subsidiary, is an operator of several metal recycling facilities in Virginia, Ohio and North Carolina. At these facilities, the company is involved in collecting, classifying, and processing raw scrap metal (ferrous and nonferrous) for recycling. The company involves collecting, classifying and processing appliances, construction material, end-of-life vehicles, boats, and industrial machinery and processing those items by crushing, shearing, shredding, separating, and sorting, into smaller pieces and categorize these recycled ferrous, nonferrous, and mixed metal pieces based on density and metal prior to sale.